Kalfostym 50 ml

Kalfostim, 50 ml
Composition
100 ml of the preparation contains active ingredients:

calcium gluconate – 32.82 g,
calcium glycerophosphate – 8.13 g,
magnesium chloride – 4.18 g.
Excipients: boric acid, sodium citrate, water for injection.

Pharmacological properties
Kalfostim is a complex preparation. The effect of the drug is due to the pharmacological properties of the active substances that make up its composition.

Calcium is involved in the formation of bone tissue (prevents the risk of rickets and osteodystrophy), in the process of blood coagulation, in the regulation of the processes of nerve conduction and muscle contractions, in maintaining stable cardiac activity. It has tonic, antitoxic effects.

Phosphorus is one of the main elements of bone tissue, nucleoproteins and phospholipids. It participates in all assimilation processes in the body of the animal, has a positive effect on the metabolism in the tissues of the body.

Magnesium participates in the metabolism of phosphorus and carbohydrates as a coenzyme. When administered parenterally, it blocks neuromuscular transmission and prevents the development of seizures.

The active substances “Kalfostim” are in a physiologically grounded ratio, well and quickly absorbed when administered parenterally.

“Kalfostim” is low-toxic, well tolerated by animals of different ages, in the recommended doses it does not have a local irritating, sensitizing, teratogenic and embryotoxic effect, does not have cumulative properties.

Application
Treatment and prevention of animals with diseases associated with impaired metabolism of calcium, phosphorus and magnesium:

hypocalcemia (postpartum paresis, rickets in young animals, osteomalacia in old animals) various forms of tetany (transport and pasture tetany, tetany during pregnancy and lactation);
allergies, toxicosis, postpartum hemoglobinuria, spotted disease, urticaria; exanthema, hemorrhagic diathesis, hematuria and myoglobinuria;
paresis due to calcium and phosphorus deficiency of various etiologies;
adjuvant therapy for intoxication with lead, fluorine or oxalic acid.
Dosage
The drug is administered intravenously, intramuscularly or subcutaneously at a dose:

Animal species Dose in ml per animal Route of administration
Horses weighing up to 500 kg 80-100 Intravenous.
Cattle weighing up to 500 kg (different ages) 80-100 Intravenous.
Intramuscularly (the maximum dose for administration in one place is not more than 25 ml).
Subcutaneously (the maximum dose for administration in one place is not more than 50 ml).
Sheep, goats (of different ages) 15-25 Intravenous.
Intramuscularly (the maximum dose for administration in one place is not more than 15 ml).
Subcutaneously.
Pigs 15-25 Intravenous.
Intramuscularly (the maximum dose for administration in one place is not more than 15 ml).
Subcutaneously.
Piglets 2-3 Intramuscularly.
Subcutaneously.
For therapeutic purposes, Kalfostim is prescribed to animals once. It is allowed to re-use the drug after 24 hours at the doses indicated in the table.

For the prevention of metabolic disorders of calcium, phosphorus and magnesium during pregnancy, lactation, as well as rickets of young farm animals, Kalfostim is used once in the recommended doses.

Contraindications
Hypercalcemia, acidosis, impaired renal function, excessive nervous excitement, ventricular fibrillation, hypersensitivity to the components of the drug.

Storage
Store in a dry, dark place out of the reach of children at a temperature of 5 ° C to 25 ° C

Shelf life – 3 years, after opening the bottle – 28 days.